查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1865451

全球固态和液体製药生产自动化市场预测至2032年：按剂型、包装类型、技术、应用、最终用户和地区分類的全球分析

Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Forecasts to 2032 - Global Analysis By Dosage Form, Packaging Type, Technology, Application, End User and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

据 Stratistics MRC 称，2025 年全球固态和液体剂型製药生产过程自动化市场规模预计将达到 70 亿美元，到 2032 年将达到 150 亿美元，预测期内复合年增长率为 11.5%。

在製药生产中，自动化是指利用控制系统运作固态（片剂、胶囊）和液体（糖浆、注射）生产设备，最大限度地减少人为干预。这包括分装、混合、製粒、压片、填充和包装等流程。自动化能够提高生产精度和效率，并加强对严格法规的遵守。透过确保产品品质的稳定性、降低污染风险以及提高批次可追溯性，自动化对于扩大生产规模和维持良好生产规范 (GMP) 至关重要。

根据 Springer 出版的《治疗创新与监管科学》杂誌报道，人工智慧 (AI) 正在透过实现数据驱动的优化来改变液体药物製剂，提高药物发现、製剂设计和生产的效率，并减少对试验法的依赖。

对生产效率的需求不断增长

对提高生产效率的日益重视正推动固态和液体製剂製药生产中自动化技术的应用。减少人工干预、提高精度和优化生产效率的需求日益增长，促使製造商投资先进的自动化系统。自动化解决方案能够简化操作、缩短週期时间并确保品质稳定，尤其对于复杂剂型更是如此。此外，机器人和人工智慧驱动的控制系统的整合提高了製程可靠性，确保符合监管标准并实现製药生产的扩充性。

大笔初始投资

儘管自动化具有许多优势，但高昂的初始投资仍是製药製剂生产自动化广泛应用的主要障碍。机器人、视觉检测和数位监控技术的整合需要大量资金，尤其对于中小企业而言更是如此。此外，客製化和验证成本进一步加重了财务负担。严格的合规要求和复杂的维护流程也促使许多公司推迟采用自动化技术。这导致投资回收期延长，并限制了该技术在新兴製药生产环境中的快速普及。

个性化医疗包装的发展

个人化医疗的兴起为製药生产创造了盈利的自动化机会。随着定製剂型和患者特异性治疗方法的日益普及，自动化包装和给药系统能够确保精确度和灵活性。先进的机器人技术和自适应控制技术实现了批次级客製化和即时调整。在以人为本的给药需求驱动下，自动化有助于减少错误、增强可追溯性并简化小批量生产。因此，製药公司正在采用数位自动化来支持其基于个人化和精准性的药物包装流程的扩充性。

供应链中断影响自动化

全球供应链中断对自动化主导的製药生产构成重大威胁。半导体供应中断、设备物流中断和零件短缺会阻碍系统整合和试运行。此外，对专业供应商的自动化组件依赖会加剧地缘政治紧张局势下的脆弱性。材料成本波动和安装延误会增加生产连续性风险。因此，企业越来越重视在地化筹资策略和建立具有韧性的供应商网络，以减少自动化停机时间并维持製药生产线的运作可靠性。

新冠疫情的影响：

由于对不间断生产的需求激增，新冠肺炎疫情加速了固态和液体製剂生产中自动化技术的应用。劳动力短缺和保持社交距离的规定促使企业转向机器人搬运和自动化检测系统。此外，远端监控和数数位双胞胎技术也为预测性维护和品管提供了支援。然而，疫情初期的封锁措施延缓了设备的采购和安装。随着时间的推移，这场危机更加凸显了自动化的战略必要性，提升了生产的灵活性，并增强了整个製药生产流程的韧性。

预计在预测期内，固态製剂自动化细分市场将占据最大的市场份额。

预计在预测期内，固态製剂自动化领域将占据最大的市场份额，这主要得益于其在片剂压制、包衣和包装流程中的广泛应用。製造商对大规模片剂生产中精度和可重复性的重视，推动了自动化技术的应用。在对一致性和合规性需求的驱动下，自动化系统提高了生产效率和品管水准。此外，该领域还受益于对机器人配料、自动填充和检测单元投资的增加，这些设备有助于减少操作变异性。

预计在预测期内，初级包装自动化领域将实现最高的复合年增长率。

由于对产品安全和污染预防的需求不断增长，预计在预测期内，初级包装自动化领域将实现最高成长率。在严格的监管要求推动下，自动化初级包装系统提高了密封精度并最大限度地减少了人为接触。此外，固态和液体剂型产品向泡壳、小袋包装和管瓶包装的转变也加速了这一领域的应用。机器视觉和人工智慧的集成，确保了标籤的准确性和可追溯性，进一步推动了该领域的扩张。

占比最大的地区：

亚太地区预计将在预测期内保持最大的市场份额，这主要得益于中国、印度和韩国製药业的快速扩张。政府鼓励工业自动化和投资先进生产设施的激励措施正在推动成长。此外，学名药产量的增加和契约製造活动的活性化也促进了自动化整合。该地区不断增长的熟练劳动力和经济高效的实施环境进一步巩固了其在固态和液体製剂生产自动化应用方面的领先地位。

复合年增长率最高的地区：

在预测期内，由于北美地区大力推进数位转型并率先采用新技术，该地区有望实现最高的复合年增长率。该地区完善的法规结构有利于透过自动化进行流程验证。此外，对智慧工厂和数据驱动型製造的投资不断增加，也提升了生产的灵活性。在个人化医疗日益受到重视以及美国食品药物管理局（FDA）严格监管的推动下，美国和加拿大各地的药品生产设施的自动化应用持续激增。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争基准化分析
    • 根据主要参与者的产品系列、地理覆盖范围和策略联盟基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球固态和液体製药生产自动化市场（按剂型划分）

  • 固态剂量自动化
    • 片剂生产
    • 胶囊填充和密封系统
    • 製粒、混合和压缩控制
  • 液体剂型自动化
    • 糖浆和悬浮液的生产
    • 无菌填充和灭菌系统
    • 液体混合和均质化
  • 半固态製剂自动化
    • 软膏和乳霜的生产
    • 凝胶和糊状物混合系统
    • 管材填充和密封

6. 全球固态和液体製药生产自动化市场（按包装类型划分）

  • 初级包装自动化
    • 泡壳包装机
    • 瓶装填充和封盖系统
    • 条状包装设备
    • 管瓶和安瓿包装
    • 小袋和包装袋填充系统
  • 二级包装自动化
    • 纸箱和包装箱系统
    • 捆扎、包装、收缩包装
    • 序列化和聚合系统
    • 码垛、卸垛和贴标机器人
  • 三级包装自动化
    • 用于仓库作业的自动导引车 (AGV)
    • 散装搬运和运输货柜系统

7. 全球固态和液体製药生产自动化市场（按技术划分）

  • 机器人和取放系统
  • 视觉检测系统
  • 标籤和序列化系统
  • 输送机和自动化物料搬运
  • 吹塑-填充-密封（BFS）技术
  • 成型-填充-密封（FFS）系统

8. 全球固态和液体製药生产自动化市场（按应用领域划分）

  • 药物发现与开发
  • 临床试验材料生产
  • 商业化生产与加工
    • 活性药物成分（API）生产
    • 配方和组成
  • 品管和法规遵从
  • 物流和库存管理

9. 全球固态和液体製药生产自动化市场（按最终用户划分）

  • 製药公司
  • 生技公司
  • 合约研发生产组织（CDMO/CMO）
  • 研究和学术机构
  • 包装和设备製造商

10. 全球固态和液体製药生产自动化市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十二章 企业概况

  • Siemens Healthineers
  • Rockwell Automation
  • Bosch Packaging Technology
  • Syntegon Technology
  • Korber Pharma
  • Becton Dickinson（BD）
  • IMA Group
  • Marchesini Group
  • OPTIMA Packaging Group
  • Uhlmann Pac-Systeme
  • Omnicell Inc.
  • ARxIUM
  • Yuyama Co., Ltd.
  • Mitsubishi Electric
  • Honeywell Process Solutions
  • GEA Group
  • Thermo Fisher Scientific
  • Schneider Electric
Product Code: SMRC32165

According to Stratistics MRC, the Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market is accounted for $7.0 billion in 2025 and is expected to reach $15.0 billion by 2032 growing at a CAGR of 11.5% during the forecast period. Automation in pharmaceutical manufacturing involves using control systems to operate equipment for producing solid (tablets, capsules) and liquid (syrups, injections) dosage forms with minimal human intervention. It encompasses processes like dispensing, mixing, granulation, compression, filling, and packaging. This enhances precision, efficiency, and compliance with stringent regulations. By ensuring consistent product quality, reducing contamination risks, and improving batch traceability, automation is vital for scaling up production and maintaining Good Manufacturing Practice (GMP).

According to Springer's Therapeutic Innovation & Regulatory Science journal, artificial intelligence is transforming liquid dosage formulation by enabling data-driven optimization. AI improves efficiency in drug discovery, formulation, and manufacturing, reducing reliance on trial-and-error methods

Market Dynamics:

Driver:

Rising demand for production efficiency

The increasing focus on improving production efficiency is propelling automation adoption in solid and liquid dosage pharmaceutical manufacturing. Fueled by the growing need to minimize manual intervention, enhance precision, and optimize throughput, manufacturers are investing in advanced automated systems. Automation solutions streamline operations, reduce cycle times, and ensure consistent quality, particularly in complex dosage formulations. Moreover, the integration of robotics and AI-driven control systems enhances process reliability, ensuring compliance with regulatory standards and scalability in pharmaceutical output.

Restraint:

High initial capital investment

Despite its benefits, high upfront investment acts as a key barrier to widespread automation deployment in pharmaceutical dosage manufacturing. The integration of robotics, vision inspection, and digital monitoring technologies requires significant capital, particularly for small and mid-sized firms. Additionally, customization and validation costs further elevate financial burdens. Spurred by stringent compliance requirements and maintenance complexities, many firms delay automation adoption. Consequently, the return on investment period extends, limiting faster technological penetration across developing pharmaceutical production environments.

Opportunity:

Growth in personalized medicine packaging

The emergence of personalized medicine is unlocking lucrative automation opportunities in pharmaceutical manufacturing. As customized dosage forms and patient-specific therapies gain traction, automated packaging and dosing systems ensure precision and flexibility. Advanced robotics and adaptive control technologies enable batch-level customization and real-time adjustments. Driven by the demand for individual-centric drug delivery, automation helps reduce errors, enhance traceability, and streamline small-batch production. Consequently, pharmaceutical players are adopting digital automation to support the scalability of personalized and precision-based drug packaging processes.

Threat:

Supply chain disruptions impact automation

Global supply chain disruptions pose a substantial threat to automation-driven pharmaceutical manufacturing. Interruptions in semiconductor availability, equipment logistics, and component shortages hinder system integration and commissioning. Moreover, dependency on specialized vendors for automation components amplifies vulnerability during geopolitical tensions. Spurred by fluctuating material costs and delayed installations, production continuity risks rise. Hence, companies increasingly focus on regionalized sourcing strategies and resilient supplier networks to mitigate automation downtime and maintain operational reliability in dosage manufacturing lines.

Covid-19 Impact:

The COVID-19 pandemic accelerated automation adoption across solid and liquid dosage manufacturing due to heightened demand for uninterrupted production. Fueled by labor shortages and social distancing norms, companies turned to robotic handling and automated inspection systems. Additionally, remote monitoring and digital twin technologies supported predictive maintenance and quality control. However, initial lockdowns delayed equipment procurement and installation. Over time, the crisis reinforced the strategic necessity for automation, transforming production agility and reinforcing resilience across pharmaceutical manufacturing workflows.

The solid dosage form automation segment is expected to be the largest during the forecast period

The solid dosage form automation segment is expected to account for the largest market share during the forecast period, propelled by its extensive application in tablet compression, coating, and packaging operations. Manufacturers are emphasizing precision and repeatability in large-scale tablet production, driving automation uptake. Fueled by demand for consistency and compliance, automated systems enhance throughput and quality control. Additionally, the segment benefits from increasing investments in robotic dispensing, automated filling, and inspection units that reduce operational variability.

The primary packaging automation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the primary packaging automation segment is predicted to witness the highest growth rate, influenced by rising requirements for product safety and contamination prevention. Driven by stringent regulatory mandates, automated primary packaging systems enhance sealing precision and minimize human contact. Furthermore, the growing shift toward blister, sachet, and vial packaging for both solid and liquid dosage forms accelerates adoption. Integration of machine vision and AI ensures labeling accuracy and traceability, boosting this segment's expansion trajectory.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by rapid pharmaceutical manufacturing expansion in China, India, and South Korea. Government incentives supporting industrial automation and investments in advanced production facilities bolster growth. Additionally, rising generics output and contract manufacturing activities enhance automation integration. The region's growing pool of skilled engineers and cost-effective deployment environments further strengthen its leadership in automated solid and liquid dosage manufacturing adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong digital transformation initiatives and early technology adoption among major pharmaceutical firms. The region's established regulatory framework encourages process validation through automation. Additionally, increasing investments in smart factories and data-driven manufacturing enhance production agility. Fueled by a growing focus on personalized medicine and stringent FDA compliance, automation uptake continues to surge across U.S. and Canadian dosage production facilities.

Key players in the market

Some of the key players in Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, Bosch Packaging, Syntegon, Korber Pharma, Becton Dickinson, IMA Group, Marchesini, OPTIMA Packaging, Uhlmann Pac-Systeme, Omnicell, ARxIUM, Yuyama Co., Ltd., Mitsubishi Electric, Honeywell, GEA Group, Thermo Fisher, and Schneider Electric.

Key Developments:

In September 2025, Siemens and Merck extended their strategic partnership to accelerate digital transformation in pharmaceutical manufacturing. The collaboration aims to integrate Merck's SaaS products with Siemens' digital ecosystem, deploying AI tools for smarter, faster drug development using technology from Siemens' July 2025 Dotmatics acquisition.

In October 2025, Rockwell Automation launched the ControlLogix 5590 Controller, a next-generation platform designed for advanced industrial and pharmaceutical automation, featuring integrated safety and multidiscipline control for streamlined manufacturing.

In May 2025, Syntegon premiered its SynTiso line for automated liquid pharmaceutical filling, developed in direct collaboration with two major pharmaceutical partners, to enhance automation and yield while reducing operator intervention.

Dosage Forms Covered:

  • Solid Dosage Form Automation
  • Liquid Dosage Form Automation
  • Semisolid Dosage Form Automation

Packaging Types Covered:

  • Primary Packaging Automation
  • Secondary Packaging Automation
  • Tertiary Packaging Automation

Technologies Covered:

  • Robotics & Pick-and-Place Systems
  • Vision Inspection Systems
  • Labeling & Serialization Systems
  • Conveyors & Automated Material Handling
  • Blow-Fill-Seal (BFS) Technology
  • Form-Fill-Seal (FFS) Systems

Applications Covered:

  • Drug Discovery & Development
  • Clinical Trial Material Manufacturing
  • Commercial Production &Processing
  • Quality Control & Regulatory Compliance
  • Logistics & Inventory Management

End Users Covered:

  • Pharmaceutical Manufacturing Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • Research and Academic Institutions
  • Packaging & Equipment Manufacturers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Dosage Form

  • 5.1 Introduction
  • 5.2 Solid Dosage Form Automation
    • 5.2.1 Tablet Manufacturing
    • 5.2.2 Capsule Filling & Sealing Systems
    • 5.2.3 Granulation, Blending & Compression Control
  • 5.3 Liquid Dosage Form Automation
    • 5.3.1 Syrup & Suspension Production
    • 5.3.2 Aseptic Filling & Sterilization Systems
    • 5.3.3 Liquid Mixing & Homogenization
  • 5.4 Semisolid Dosage Form Automation
    • 5.4.1 Ointment & Cream Manufacturing
    • 5.4.2 Gel & Paste Mixing Systems
    • 5.4.3 Tube Filling & Sealing

6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Packaging Type

  • 6.1 Introduction
  • 6.2 Primary Packaging Automation
    • 6.2.1 Blister Packaging Machines
    • 6.2.2 Bottle Filling & Capping Systems
    • 6.2.3 Strip Packaging Equipment
    • 6.2.4 Vial and Ampoule Packaging
    • 6.2.5 Sachet and Pouch Filling Systems
  • 6.3 Secondary Packaging Automation
    • 6.3.1 Cartoning & Case Packing Systems
    • 6.3.2 Bundling, Wrapping, & Shrink Packaging
    • 6.3.3 Serialization & Aggregation Systems
    • 6.3.4 Palletizing, Depalletizing, & Labeling Robots
  • 6.4 Tertiary Packaging Automation
    • 6.4.1 Automated Guided Vehicles (AGVs) for Warehouse Handling
    • 6.4.2 Bulk Handling and Shipping Container Systems

7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Technology

  • 7.1 Introduction
  • 7.2 Robotics & Pick-and-Place Systems
  • 7.3 Vision Inspection Systems
  • 7.4 Labeling & Serialization Systems
  • 7.5 Conveyors & Automated Material Handling
  • 7.6 Blow-Fill-Seal (BFS) Technology
  • 7.7 Form-Fill-Seal (FFS) Systems

8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Discovery & Development
  • 8.3 Clinical Trial Material Manufacturing
  • 8.4 Commercial Production &Processing
    • 8.4.1 Active Pharmaceutical Ingredient (API) Manufacturing
    • 8.4.2 Formulation and Compounding
  • 8.5 Quality Control & Regulatory Compliance
  • 8.6 Logistics & Inventory Management

9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Manufacturing Companies
  • 9.3 Biotechnology Companies
  • 9.4 Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • 9.5 Research and Academic Institutions
  • 9.6 Packaging & Equipment Manufacturers

10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Siemens Healthineers
  • 12.2 Rockwell Automation
  • 12.3 Bosch Packaging Technology
  • 12.4 Syntegon Technology
  • 12.5 Korber Pharma
  • 12.6 Becton Dickinson (BD)
  • 12.7 IMA Group
  • 12.8 Marchesini Group
  • 12.9 OPTIMA Packaging Group
  • 12.10 Uhlmann Pac-Systeme
  • 12.11 Omnicell Inc.
  • 12.12 ARxIUM
  • 12.13 Yuyama Co., Ltd.
  • 12.14 Mitsubishi Electric
  • 12.15 Honeywell Process Solutions
  • 12.16 GEA Group
  • 12.17 Thermo Fisher Scientific
  • 12.18 Schneider Electric

List of Tables

  • Table 1 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Dosage Form (2024-2032) ($MN)
  • Table 3 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Solid Dosage Form Automation (2024-2032) ($MN)
  • Table 4 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tablet Manufacturing (2024-2032) ($MN)
  • Table 5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Capsule Filling & Sealing Systems (2024-2032) ($MN)
  • Table 6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Granulation, Blending & Compression Control (2024-2032) ($MN)
  • Table 7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Dosage Form Automation (2024-2032) ($MN)
  • Table 8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Syrup & Suspension Production (2024-2032) ($MN)
  • Table 9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Aseptic Filling & Sterilization Systems (2024-2032) ($MN)
  • Table 10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Mixing & Homogenization (2024-2032) ($MN)
  • Table 11 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Semisolid Dosage Form Automation (2024-2032) ($MN)
  • Table 12 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Ointment & Cream Manufacturing (2024-2032) ($MN)
  • Table 13 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Gel & Paste Mixing Systems (2024-2032) ($MN)
  • Table 14 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tube Filling & Sealing (2024-2032) ($MN)
  • Table 15 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging Type (2024-2032) ($MN)
  • Table 16 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Primary Packaging Automation (2024-2032) ($MN)
  • Table 17 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blister Packaging Machines (2024-2032) ($MN)
  • Table 18 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bottle Filling & Capping Systems (2024-2032) ($MN)
  • Table 19 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Strip Packaging Equipment (2024-2032) ($MN)
  • Table 20 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vial and Ampoule Packaging (2024-2032) ($MN)
  • Table 21 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Sachet and Pouch Filling Systems (2024-2032) ($MN)
  • Table 22 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Secondary Packaging Automation (2024-2032) ($MN)
  • Table 23 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Cartoning & Case Packing Systems (2024-2032) ($MN)
  • Table 24 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bundling, Wrapping, & Shrink Packaging (2024-2032) ($MN)
  • Table 25 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Serialization & Aggregation Systems (2024-2032) ($MN)
  • Table 26 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Palletizing, Depalletizing, & Labeling Robots (2024-2032) ($MN)
  • Table 27 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tertiary Packaging Automation (2024-2032) ($MN)
  • Table 28 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Automated Guided Vehicles (AGVs) for Warehouse Handling (2024-2032) ($MN)
  • Table 29 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bulk Handling and Shipping Container Systems (2024-2032) ($MN)
  • Table 30 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 31 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Robotics & Pick-and-Place Systems (2024-2032) ($MN)
  • Table 32 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vision Inspection Systems (2024-2032) ($MN)
  • Table 33 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Labeling & Serialization Systems (2024-2032) ($MN)
  • Table 34 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Conveyors & Automated Material Handling (2024-2032) ($MN)
  • Table 35 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blow-Fill-Seal (BFS) Technology (2024-2032) ($MN)
  • Table 36 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Form-Fill-Seal (FFS) Systems (2024-2032) ($MN)
  • Table 37 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Application (2024-2032) ($MN)
  • Table 38 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
  • Table 39 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Clinical Trial Material Manufacturing (2024-2032) ($MN)
  • Table 40 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Commercial Production &Processing (2024-2032) ($MN)
  • Table 41 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2024-2032) ($MN)
  • Table 42 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Formulation and Compounding (2024-2032) ($MN)
  • Table 43 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Quality Control & Regulatory Compliance (2024-2032) ($MN)
  • Table 44 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Logistics & Inventory Management (2024-2032) ($MN)
  • Table 45 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By End User (2024-2032) ($MN)
  • Table 46 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Pharmaceutical Manufacturing Companies (2024-2032) ($MN)
  • Table 47 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
  • Table 48 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs/CMOs) (2024-2032) ($MN)
  • Table 49 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)
  • Table 50 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging & Equipment Manufacturers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.